Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
Go back to Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update| (NASDAQ: ACXP) | Delayed: 1.57 -0.08 (4.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.65 | 52 Week High | $ | |||
| Open | $1.63 | 52 Week Low | $ | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.56 | EPS | $ | |||
| Volume | 52,199 | |||||

